National Institutes of Health
Atopic Dermatitis Research Network (ADRN) (U19 Clinical Trial Optional)
Atopic Dermatitis Research Network (ADRN) (U19 Clinical Trial Optional) is a funding opportunity from National Institutes of Health, closing September 24, 2026.
Sep 24, 2026
(55d left)Overview
The purpose of this notice of funding opportunity (NOFO) is to solicit applications for the Atopic Dermatitis Research Network (ADRN) program. The ADRN program will support Centers that integrate clinical and translational research to improve our understanding and management of atopic dermatitis with emphasis on…